Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2022-08-18 00:00:00 ET · period of report 2022-08-16 · accession 0001493152-22-023472 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-18 | 2022-08-16 | JBIO | Dake Benjamin T | See Remarks | S - Sale+OE | $23.00 | -21.0K | 0 | -100% | -$483.0K |
| D | 2022-08-18 | 2022-08-16 | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $1.74 | +21.0K | 21.0K | New | +$36.5K |
| DM | 2022-08-18 | 2022-08-16 | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $0.00 | -21.0K | 54.5K | -28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-16 | S | D | 10,475 | $22.44 | 10,525 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.92 to $22.915, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2022-08-16 | S | D | 7,074 | $23.29 | 3,451 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.94 to $23.94, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2022-08-16 | M | A | 21,000 | $1.74 | 21,000 | D | — | — | |
| 4 | Common | Common Stock | 2022-08-16 | S | D | 3,451 | $24.10 | 0 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.95 to $24.57, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-08-16 | M | D | 3,189 | $0.00 | 15,394 | D | $1.74 · — to 2030-09-03 | 3,189 Common Stock | (F5) A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-08-16 | M | D | 17,811 | $0.00 | 54,514 | D | $1.74 · — to 2030-09-03 | 17,811 Common Stock | (F6) A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |